<DOC>
	<DOCNO>NCT00002893</DOCNO>
	<brief_summary>RATIONALE : Palliative chemotherapy may help patient advanced colorectal cancer live long comfortably . PURPOSE : Randomized phase III trial compare effectiveness quality life follow three different palliative chemotherapy regimen treat patient advanced metastatic recurrent colorectal cancer .</brief_summary>
	<brief_title>Palliative Chemotherapy Treating Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare survival quality life patient metastatic recurrent colorectal cancer receive palliative therapy leucovorin/fluorouracil vs. continuous-infusion fluorouracil vs. ICI D1694 . II . Compare survival quality life patient stable respond disease 12 week initial treatment randomize receive 12 additional week chemotherapy vs. treatment . OUTLINE : This randomize study . Patients stratify participate institution . Patients randomize one three treatment regimen . The first group receive leucovorin follow fluorouracil every 14 day total 6 course . The second group receive continuous-infusion fluorouracil 12 week . The third group receive ICI D1694 every 21 day total 4 course . Patients without progressive disease excessive toxicity 12 week treatment randomize receive continue chemotherapy 12 weekly cycle assign chemotherapy proceed observation therapy , evidence disease progression . Patients follow every 6 week . PROJECTED ACCRUAL : A total 900 patient enter .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Raltitrexed</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon rectum one follow category : Locally advance , metastatic , recurrent disease suitable palliative chemotherapy Evaluable disease outside prior radiotherapy field Patients disease confine liver refer protocol MRCCR05 PATIENT CHARACTERISTICS : Age : Not specify Performance status : WHO 02 Life expectancy : Greater 3 month Hematopoietic : WBC least 4,000 ANC least 2,000 Platelets least 100,000 Hepatic : Not specify Renal : Creatinine great 1.25 time normal OR Creatinine clearance great 65 mL/min Cardiovascular : No uncontrolled heart failure No uncontrolled angina Other : No uncontrolled medical illness ( include infection ) Able willing complete qualityoflife questionnaires No prior concurrent malignancy likely interfere protocol treatment evaluation PRIOR CONCURRENT THERAPY : No prior systemic chemotherapy except fluorouracilbased adjuvant regimen ( e.g. , QUASAR ) At least 6 month since chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>